Comparison of guideline-based control definitions and associations with outcomes in severe or difficult-to-treat asthma

被引:19
作者
Campbell, Jonathan D. [1 ]
Blough, David K. [1 ]
Sullivan, Sean D. [1 ]
机构
[1] Univ Washington, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA
关键词
D O I
10.1016/S1081-1206(10)60285-2
中图分类号
R392 [医学免疫学];
学科分类号
100102 [免疫学];
摘要
Background: The National Asthma Education and Prevention Program put forth guidance on how to measure asthma control. This guidance is flexible regarding how the impairment component of control is assessed. Objectives: To evaluate and compare 3 different National Asthma Education and Prevention Program-informed definitions of asthma control and to explore the strength of association between levels of asthma control and future control, asthma-related costs, and health-related quality-of-life utilities. Methods: We used descriptive statistics, the weighted K statistic, and regression methods to compare 3 definitions in a large registry cohort and to explore associations with clinical and health economic outcomes. Results: We followed up 3,061 patients (>= 12 years old) in a representative sample of severe or difficult-to-treat asthma. At baseline, 9.1%, 17.1%, or 33.5% of patients were considered well controlled depending on the definition. Lung function was not a component of the definition where 33.5% of patients were well controlled. Weighted K statistics comparing the baseline control definitions ranged from 0.36 to 0.67. The adjusted R 2 statistic from the models predicting the future odds of being well controlled, mean asthma-related costs, and mean utilities did not yield consistent results for ranking the definitions of control. Conclusions: Although all 3 control definitions were correlated with future control and health economic outcomes, there were striking differences in the descriptive results across the definitions, including the proportion of patients in each category of control. Differences among definitions of asthma control may lead to divergent research conclusions or treatment practices. We do not advocate for one particular definition, but we call for standardization of control definitions for specific uses.
引用
收藏
页码:474 / 481
页数:8
相关论文
共 33 条
[1]
[Anonymous], 2016, Global strategy for asthma management and prevention
[2]
Can guideline-defined asthma control be achieved? The gaining optimal asthma control study [J].
Bateman, ED ;
Boushey, HA ;
Bousquet, J ;
Busse, WW ;
Clark, TJH ;
Pauwels, RA ;
Pedersen, SE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (08) :836-844
[3]
Cost-effectiveness of asthma control: an economic appraisal of the GOAL study [J].
Briggs, AH ;
Bousquet, J ;
Wallace, MV ;
Busse, WW ;
Clark, TJH ;
Pedersen, SE ;
Bateman, ED .
ALLERGY, 2006, 61 (05) :531-536
[4]
Asthma control, severity, and quality of life: Quantifying the effect of uncontrolled disease [J].
Chen, Hubert ;
Gould, Michael K. ;
Blanc, Paul D. ;
Miller, Dave P. ;
Kamath, Tripthi V. ;
Lee, June H. ;
Sullivan, Sean D. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (02) :396-402
[6]
Assessment of variations in control of asthma over time [J].
Combescure, C ;
Chanez, P ;
Saint-Pierre, P ;
Daurès, JP ;
Proudhon, H ;
Godard, P .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (02) :298-304
[7]
Design and baseline characteristics of The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma [J].
Dolan, CM ;
Fraher, KE ;
Bleecker, ER ;
Borish, L ;
Chipps, B ;
Hayden, ML ;
Weiss, S ;
Zheng, BY ;
Johnson, C ;
Wenzel, S .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2004, 92 (01) :32-39
[8]
*ERS ATS ASTHM CON, 2006, EUR RESP SOC 16 ANN
[9]
Haddix AnneC., 2003, PREVENTION EFFECTIVE, V2nd
[10]
Development and validation of a questionnaire to measure asthma control [J].
Juniper, EF ;
O'Byrne, PM ;
Guyatt, GH ;
Ferrie, PJ ;
King, DR .
EUROPEAN RESPIRATORY JOURNAL, 1999, 14 (04) :902-907